Kristin Bramlage
Overview
Explore the profile of Kristin Bramlage including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
147
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Orkin S, Yodoshi T, Sun Q, Fei L, Meryum S, Arce-Clachar A, et al.
Obesity (Silver Spring)
. 2020 Nov;
29(1):171-176.
PMID: 33185977
Objective: Longitudinal studies on childhood predictors of nonalcoholic fatty liver disease (NAFLD) progression are lacking. The objective of this study was to determine whether baseline clinical or laboratory measures predict...
12.
Yodoshi T, Orkin S, Clachar A, Bramlage K, Sun Q, Fei L, et al.
J Pediatr
. 2020 Jul;
223:93-99.e2.
PMID: 32711755
Objective: To investigate the association between muscle mass and liver disease severity in pediatric patients with non-alcoholic fatty liver disease (NAFLD). Study Design: This was a retrospective study of patients...
13.
Yodoshi T, Orkin S, Arce-Clachar A, Bramlage K, Xanthakos S, Mouzaki M, et al.
Pediatr Obes
. 2020 Jul;
16(1):e12696.
PMID: 32638543
Background: Autoantibodies are frequently positive in adults with nonalcoholic fatty liver disease (NAFLD) without concurrent autoimmune hepatitis (AIH). The clinical significance of this is unknown in children. Objective: To determine...
14.
Yodoshi T, Arce-Clachar A, Sun Q, Fei L, Bramlage K, Xanthakos S, et al.
J Pediatr
. 2020 May;
222:127-133.
PMID: 32381466
Objectives: To determine the prevalence of renal impairment in a large cohort of youths with histologically confirmed nonalcoholic fatty liver disease (NAFLD), and to determine its association with liver disease...
15.
Yodoshi T, Orkin S, Arce-Clachar A, Bramlage K, Su W, Fei L, et al.
JPEN J Parenter Enteral Nutr
. 2020 Jan;
44(7):1301-1307.
PMID: 31985850
Background: A subset of patients with nonalcoholic steatohepatitis (NASH) respond to treatment with vitamin E. The characteristics of responders are not known. The objective of this study was to investigate...
16.
Seth A, Orkin S, Yodoshi T, Liu C, Fei L, Hardy J, et al.
Pediatr Obes
. 2019 Oct;
15(2):e12581.
PMID: 31657145
Background: Paediatric non-alcoholic fatty liver disease (NAFLD) is highly prevalent among children with obesity. The primary objective of this study was determining whether obesity severity is associated with NAFLD severity....
17.
Orkin S, Brokamp C, Yodoshi T, Trout A, Liu C, Meryum S, et al.
J Pediatr Gastroenterol Nutr
. 2019 Oct;
70(3):364-370.
PMID: 31651666
Background And Objectives: Nonalcoholic fatty liver disease (NAFLD) is linked to obesity. Obesity is associated with lower socioeconomic status (SES). An independent link between pediatric NAFLD and SES has not...
18.
Yodoshi T, Orkin S, Arce-Clachar A, Bramlage K, Liu C, Fei L, et al.
Eur J Clin Nutr
. 2019 Aug;
74(3):427-435.
PMID: 31444465
Background/objectives: To determine associations between serum 25-hydroxyvitamin D (25(OH)-D) concentrations and histologic nonalcoholic fatty liver disease (NAFLD) severity. Subjects/methods: Clinical, laboratory, and histology data were collected retrospectively in a pediatric...
19.
Mouzaki M, Yodoshi T, Arce-Clachar A, Bramlage K, Fei L, Ley S, et al.
J Pediatr Gastroenterol Nutr
. 2019 May;
69(3):339-343.
PMID: 31124886
Objectives: The aim of the study was to determine whether pediatric patients with nonalcoholic fatty liver disease (NAFLD) exposed to psychotropic medications have more severe liver disease compared to their...
20.
Mouzaki M, Shah A, Arce-Clachar A, Hardy J, Bramlage K, Xanthakos S
J Clin Lipidol
. 2019 Mar;
13(3):425-431.
PMID: 30879942
Background: Low-density lipoprotein cholesterol (LDL-C) levels below 50 mg/dL may suggest familial hypobetalipoproteinemia, particularly in patients with hepatic steatosis. The prevalence of hypobetalipoproteinemia in cohorts with nonalcoholic fatty liver disease...